JP2018531905A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018531905A5 JP2018531905A5 JP2018511451A JP2018511451A JP2018531905A5 JP 2018531905 A5 JP2018531905 A5 JP 2018531905A5 JP 2018511451 A JP2018511451 A JP 2018511451A JP 2018511451 A JP2018511451 A JP 2018511451A JP 2018531905 A5 JP2018531905 A5 JP 2018531905A5
- Authority
- JP
- Japan
- Prior art keywords
- thymosin
- composition containing
- container
- containing thymosin
- inert gas
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR10-2015-0140489 | 2015-10-06 | ||
| KR20150140489 | 2015-10-06 | ||
| PCT/KR2015/013981 WO2017061663A1 (ko) | 2015-10-06 | 2015-12-18 | 티모신 베타 4를 포함하는 안약의 제조방법 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020109496A Division JP2020183391A (ja) | 2015-10-06 | 2020-06-25 | チモシンベータ４を含む眼科用製剤の製造方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2018531905A JP2018531905A (ja) | 2018-11-01 |
| JP2018531905A5 true JP2018531905A5 (enExample) | 2021-10-21 |
| JP6996713B2 JP6996713B2 (ja) | 2022-02-04 |
Family
ID=58487995
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2018511451A Active JP6996713B2 (ja) | 2015-10-06 | 2015-12-18 | チモシンベータ４を含む眼科用製剤の製造方法 |
| JP2020109496A Pending JP2020183391A (ja) | 2015-10-06 | 2020-06-25 | チモシンベータ４を含む眼科用製剤の製造方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020109496A Pending JP2020183391A (ja) | 2015-10-06 | 2020-06-25 | チモシンベータ４を含む眼科用製剤の製造方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US10744088B2 (enExample) |
| EP (1) | EP3342398B1 (enExample) |
| JP (2) | JP6996713B2 (enExample) |
| KR (1) | KR102487614B1 (enExample) |
| ES (1) | ES3064258T3 (enExample) |
| HK (1) | HK1256595A1 (enExample) |
| WO (1) | WO2017061663A1 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20210251970A1 (en) | 2018-10-10 | 2021-08-19 | Presbyopia Therapies Inc | Compositions and methods for storage stable ophthalmic drugs |
| MX2021004183A (es) * | 2018-10-10 | 2021-10-26 | Presbyopia Therapies Inc | Composiciones y metodos para el tratamiento de la presbicia. |
| CN112107678B (zh) * | 2020-09-30 | 2022-11-18 | 辰欣药业股份有限公司 | 一种含有胸腺法新的冻干组合物及其制备方法 |
| US12180206B2 (en) | 2021-11-17 | 2024-12-31 | Lenz Therapeutics Operations, Inc. | Aceclidine derivatives, compositions thereof and methods of use thereof |
| CN115266995B (zh) * | 2022-08-02 | 2023-10-13 | 兆科（广州）眼科药物有限公司 | 一种生发肽制剂中有关物质的分析方法 |
| US12414942B1 (en) | 2024-03-15 | 2025-09-16 | Lenz Therapeutics Operations, Inc. | Compositions, methods, and systems for treating presbyopia |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4150744A (en) * | 1976-02-27 | 1979-04-24 | Smith & Nephew Pharmaceuticals Ltd. | Packaging |
| US6271216B1 (en) * | 1989-07-24 | 2001-08-07 | Allergan | Stable solution of hyaluronate in a balanced salt medium |
| WO1996031195A1 (en) * | 1995-04-04 | 1996-10-10 | Otsuka Pharmaceutical Co., Ltd. | Package holding a procaterol hydrochloride aqueous solution formulation, and a procaterol hydrochloride aqueous solution formulation |
| AU766826B2 (en) | 1998-07-30 | 2003-10-23 | Government of The United States of America, as represented by The Secretary Department of Health & Human Services, The National Institutes of Health, The | Thymosin beta4 promotes wound repair |
| CN1188414C (zh) * | 1998-10-14 | 2005-02-09 | 协和发酵工业株式会社 | 稳定吡唑并吖啶酮衍生物水溶液的方法 |
| BRPI0513978A (pt) * | 2004-07-30 | 2008-05-20 | Otsuka Pharma Co Ltd | frasco de comprimir e conta-gotas de uso oftalmológico utilizando o mesmo |
| KR20060051135A (ko) * | 2004-09-15 | 2006-05-19 | 니프로 가부시키가이샤 | 안정화된 주사용 수용액 제재 |
| US8383576B2 (en) * | 2005-06-17 | 2013-02-26 | Regenerx Biopharmaceuticals, Inc. | LKKTET and/or LKKTNT peptide compositions which are lyophilized or in a form capable of being lyophilized |
| ES2288118B1 (es) * | 2006-05-10 | 2008-11-01 | Bcn Peptides, S.A. | Procedimiento para sintetizar timosinas. |
| WO2008108927A2 (en) * | 2007-03-06 | 2008-09-12 | Regenerx Biopharmaceuticals, Inc. | Methods and compositions for stabilizing polypeptides |
| SI3461503T1 (sl) | 2007-04-11 | 2022-04-29 | Biomarin Pharmaceutical Inc. | Postopki za dajanje tetrahidrobiopterina, povezani sestavki in postopki merjenja |
| JP5990880B2 (ja) * | 2011-08-31 | 2016-09-14 | 東レ株式会社 | 有用タンパク質組成物およびその製造方法 |
-
2015
- 2015-12-18 JP JP2018511451A patent/JP6996713B2/ja active Active
- 2015-12-18 ES ES15905904T patent/ES3064258T3/es active Active
- 2015-12-18 US US15/752,118 patent/US10744088B2/en active Active
- 2015-12-18 EP EP15905904.7A patent/EP3342398B1/en active Active
- 2015-12-18 KR KR1020150182196A patent/KR102487614B1/ko active Active
- 2015-12-18 HK HK18115713.4A patent/HK1256595A1/en unknown
- 2015-12-18 WO PCT/KR2015/013981 patent/WO2017061663A1/ko not_active Ceased
-
2020
- 2020-06-25 JP JP2020109496A patent/JP2020183391A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103476397B (zh) | 一种制备用于注射的含培美曲塞或其盐的无抗氧化剂溶液形式的药物制剂的方法 | |
| JP6892494B2 (ja) | パラセタモール及びイブプロフェンを含む水性配合物 | |
| JP2014518844A5 (enExample) | ||
| CN102026923A (zh) | 饮料、氢还原水以及其制造方法及保存方法 | |
| CN105472996A (zh) | 氢负离子内含物的制备方法及利用其来制备的氢负离子内含物 | |
| JP2017506632A (ja) | ノルアドレナリンの安定な低濃度の注射用溶液を生成するための方法 | |
| JP6505114B2 (ja) | 抗酸化剤を含有しない薬学組成物およびその製造方法 | |
| KR20160064181A (ko) | 아세트산 및 아세트산염을 포함하는 3제형 투석용제 | |
| CN108338988A (zh) | 碳酸氢钠林格注射液及制备方法 | |
| JP2005530537A5 (enExample) | ||
| CN103848763B (zh) | 采用有机羧酸或有机羧酸盐添加剂改变牛磺酸晶体形态的方法 | |
| JP6873923B2 (ja) | 安定化された薬学組成物およびその製造方法 | |
| CN103068397B (zh) | 医用溶液用浓缩物、其制造以及其在透析中的应用 | |
| AU2015317229B2 (en) | Dialysis solution | |
| CN106132416A (zh) | 注射液制剂及其制造方法 | |
| TW201735931A (zh) | 液狀醫藥製劑 | |
| CN101180051B (zh) | 多利培南水溶液的制备方法 | |
| JPS62194861A (ja) | 液状医薬品包装体 | |
| CN109264746A (zh) | 一种药用级碳酸氢钠的制备方法 | |
| CN103936825B (zh) | 邻苯二甲酰-l-丙氨酰-l-谷氨酰胺的绿色制备方法 | |
| CN104151324A (zh) | 一种溶媒结晶法制备氨苄西林钠的方法 | |
| NO327263B1 (no) | Parenterale formuleringer som inneholder 10-hydroksy-10,11-tetrahydrokarbamazepin, enhetsdoseringsform og beholder inneholdende nevnte parenterale formulering, samt anvendelse av nevnte parenterale formulering. | |
| CN102204908B (zh) | 一种含依达拉奉化合物的药物组合物及其制备方法 | |
| JP2010047482A (ja) | エダラボン注射液 | |
| JP2003055195A (ja) | ビタミンｂ１配合末梢静脈投与用総合輸液剤 |